Asset Details
Do you wish to reserve the book?
Effect of intravitreal bevacizumab on kidney function and proteinuria among diabetic patients: a prospective observational study in Asian population
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Effect of intravitreal bevacizumab on kidney function and proteinuria among diabetic patients: a prospective observational study in Asian population
Do you wish to request the book?
Effect of intravitreal bevacizumab on kidney function and proteinuria among diabetic patients: a prospective observational study in Asian population
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Effect of intravitreal bevacizumab on kidney function and proteinuria among diabetic patients: a prospective observational study in Asian population
2026
Overview
Many studies have investigated the ocular benefits of intravitreal bevacizumab but there is scarcity of literature evaluating the effects of bevacizumab on kidney function and proteinuria especially in the Asian population. This study aims to investigate the effect of intravitreal injection of bevacizumab on proteinuria and kidney function in patients with diabetic retinopathy. This prospective observational study included 50 patients with diabetes and proliferative diabetic retinopathy (PDR) and/or significant diabetic macular edema, who have received intravitreal bevacizumab injection at a tertiary care center in India. Changes in the urinary albumin-to-creatinine ratio (UACR) and estimated glomerular filtration rate (eGFR) at one month and six months after injection were measured. This study reported no significant change in eGFR and UACR at one month (
> 0.05), but significant changes were seen at six months (
< 0.05). The subgroup with diabetic kidney disease (DKD) reported significant worsening of eGFR compared to the non-DKD subgroup. However, the DKD subgroup also had higher proteinuria and lower eGFR at baseline. Baseline UACR was a significant predictor of worsening eGFR and UACR at six months. Patients with diabetic retinopathy who received intravitreal bevacizumab injections showed significant worsening of kidney function and proteinuria at six months but not at one month. Higher baseline UACR was indicator of poor kidney outcomes. However, further studies with a control group without bevacizumab exposure are required to confirm the independent effect of intravitreal bevacizumab on kidney function and proteinuria.
Publisher
Taylor & Francis,Taylor & Francis Group
Subject
/ Adult
/ Aged
/ Angiogenesis Inhibitors - administration & dosage
/ Angiogenesis Inhibitors - adverse effects
/ anti-vascular endothelial growth factor
/ Bevacizumab - administration & dosage
/ Bevacizumab - adverse effects
/ Diabetic Nephropathies - drug therapy
/ Diabetic Retinopathy - complications
/ Diabetic Retinopathy - drug therapy
/ Female
/ Glomerular Filtration Rate - drug effects
/ Humans
/ India
/ Macular Edema - drug therapy
/ Male
